TickerFactsScreenerDevelopers

Trevi Therapeutics, Inc. (TRVI) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$18.29M2019: -$23.09M2020: -$29.00M2021: -$28.95M2022: -$28.18M2023: -$31.71M2024: -$38.26M2025: -$42.09M-$42.09M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$42.09M-10.0%
2024-$38.26M-20.6%
2023-$31.71M-12.5%
2022-$28.18M+2.7%
2021-$28.95M+0.2%
2020-$29.00M-25.6%
2019-$23.09M-26.3%
2018-$18.29M—